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Background: Recurrent airway obstruction (RAO, also known as equine heaves) is an inflammatory condition
caused by exposure of susceptible horses to organic dusts in hay. The immunological processes responsible for the
development and the persistence of airway inflammation are still largely unknown. Hypoxia-inducible factor (Hif) is
mainly known as a major regulator of energy homeostasis and cellular adaptation to hypoxia. More recently
however, Hif also emerged as an essential regulator of innate immune responses. Here, we aimed at investigating
the potential involvement of Hif1-α in myeloid cells in horse with recurrent airway obstruction.
Results: In vitro, we observed that Hif is expressed in equine myeloid cells after hay dust stimulation and regulates
genes such as tumor necrosis factor alpha (TNF-α), interleukin-8 (IL-8) and vascular endothelial growth factor A
(VEGF-A). We further showed in vivo that airway challenge with hay dust upregulated Hif1-α mRNA expression in
myeloid cells from the bronchoalveolar lavage fluid (BALF) of healthy and RAO-affected horses, with a more
pronounced effect in cells from RAO-affected horses. Finally, Hif1-α mRNA expression in BALF cells from challenged
horses correlated positively with lung dysfunction.
Conclusion: Taken together, our results suggest an important role for Hif1-α in myeloid cells during hay
dust-induced inflammation in horses with RAO. We therefore propose that future research aiming at functional
inactivation of Hif1 in lung myeloid cells could open new therapeutic perspectives for RAO.
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Recurrent airway obstruction (RAO) or heaves is a well-
known respiratory disease in horses that shares any
pathophysiological similarities with asthma in humans
[1-3]. RAO is a severe, potentially debilitating, chronic
inflammatory airway disease typically affecting middle-
aged horses. Acute exacerbations are characterized by
neutrophilic airway inflammation, coughing, periods of
labored breathing at rest and exercise intolerance due to
bronchospasm and mucus accumulation in the airways
[4]. It is initiated following exposure to organic dusts,
molds, and lipopolysaccharides (LPS) in hay [5]. Periods* Correspondence: M.Toussaint@ulg.ac.be
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reproduction in any medium, provided the orof acute exacerbation are interspersed by periods of re-
mission, when horses are kept away from the causative
environment [3]. The immunological processes respon-
sible for the persistent airway inflammation are still
largely unknown [6]. RAO is thought to result from an
aberrant immune response orchestrated by antigen-spe-
cific T lymphocytes via the secretion of pro-inflamma-
tory cytokines. Whether these T lymphocytes have a
type 1 or type 2 phenotype and cytokine secretion pro-
file is still a matter of debate [7-11]. Although little stud-
ied so far, innate immune mechanisms, which constitute
a central interface between external stimuli and the
adaptive immune system, may also play an important
role in the pathophysiology of RAO.
Hif1 is an essential regulator of adaptation to low oxy-
gen levels [12]. Hif1 is a heterodimer composed of an oxy-
gen-regulated α-subunit and a constitutively expressedral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Hif1-α mRNA relative expression (LSmean± S.E.M) in
equine monocytes 1, 2 and 4 hours after stimulation with hay
dust (500 ng/mL). The relative expression is normalized to the
geometric mean of reference genes. This experiment is
representative of three similar experiments. (*P< 0.05)
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marily regulated by a family of prolyl hydroxylases (PHD).
In normoxia, PHD is activated and directs the degradation
of the α-subunit by the ubiquitin-proteasome pathway [13].
Under hypoxia, PHD activity decreases, which leads to
the stabilization and translocation to the nucleus of the
α-subunits which heterodimerize with the β-subunit.
This dimer recognizes the hypoxia response elements
(HREs) to induce target gene expression. Hif1 activity is
primarily regulated by the abundance of the Hif1-α sub-
unit [14]. Since Hif1 is highly involved in the adaptation
of cellular metabolism to hypoxic condition, it was also
proposed that Hif1 is an important promoter of inflam-
matory responses, which most often require innate im-
mune cells to adapt to oxygen-deprived inflammatory
environments [15,16]. Indeed, it was found that Hif1
regulates many pro-inflammatory genes such as tumor
necrosis factor alpha (TNF-α), interleukin-8 (IL-8) and
vascular endothelial growth factor A (VEGF-A) [17].
Hif1 was furthermore found to engage in cross-talk with
another major pro-inflammatory pathway, the Nuclear
Factor (NF)- κB pathway [18]. Although most studies fo-
cused on hypoxic conditions, Hif may promote inflam-
matory functions of myeloid cells also in normoxic
conditions [19,20]. Indeed, Hif1-α may be indirectly acti-
vated in myeloid cells by pro-inflammatory stimuli such
as LPS and the pro-inflammatory cytokine TNF-α
[21,22]. After LPS or cytokine stimulation, NF-κB pro-
motes Hif1-α gene transcription, promoting its accumu-
lation in spite of post-translational degradation [18,23].
In myeloid cells, hypoxia through decreased Hif1-α deg-
radation and inflammatory stimuli through increased
Hif1-α transcription may synergistically potentiate the
activation of Hif1.
We hypothesized that, because myeloid cells are impli-
cated in RAO, and because Hif1 is a major regulator of
the pro-inflammatory functions of myeloid cells, Hif1
could play a role in the pathophysiology of RAO. To test
this hypothesis, complementary in vitro and in vivo
approaches were undertaken.
Firstly we assessed in vitro expression of Hif1 mRNA
and its target genes in horse myeloid cells in response to
hay dust. Secondly, in vivo, we analyzed whether hay
dust-induced lung inflammation in RAO-affected horses
correlated with increased Hif1 expression in lung mye-
loid cells. Finally, we tested whether increased Hif1 ex-
pression in BALF myeloid cells correlated with clinical
variables in RAO-affected horses.
Results
Hif1- is expressed basally and upregulated by hay dust in
horse myeloid cells
We first tested the presence of Hif1 in horse myeloid
cells and assessed hay dust-induced Hif1 activation inthese cells. Relative Hif1-α mRNA expression between
excipient- and hay dust-treated monocytes was assessed
1, 2 and 4 hours after stimulation. The Hif1-α mRNA
was expressed basally and this expression was signifi-
cantly higher in stimulated than in unstimulated-cells
1 h after the beginning of the treatment, and maximal
induction was achieved after a 2 h incubation period. At
4 h, Hif1-α expression was maintained at a high level
(Figure 1).Hay dust induced pro-inflammatory genes associated
with Hif1-α activity in equine monocytes
We next aimed at determining whether hay dust-
induced Hif1-α mRNA upregulation may result in
increased Hif1 activity in equine monocytes. Hay dust
suspensions induced a significant increase in VEGF-A,
IL-8 and TNF-α expression in equine monocytes as
compared with excipient-treated monocytes (Figure 2).
We observed strong positive correlation between Hif1-α
induction and cytokine expression (Hif1-α/VEGF-A:
r = 0.92; Hif1-α/IL-8: r = 0.86; Hif1-α/TNF-α: r = 0.81).
Suggesting that the in vitro induction of cytokine expres-
sion was dependent on Hif1-α activity, noscapine, an in-
hibitor of the stabilization of Hif1-α, when added to
the culture 1 h before challenge with hay dust, inhib-
ited the induction of VEGF-A and IL-8. However, a
lower effect of noscapine was observed for TNF-α. For
IL-8, VEGF-A and TNF-α, some significant differences
were still seen between excipient- and noscapine/hay
dust-treated groups at all-time points tested. These
data support that during hay dust stimulation, Hif1-α
was partially required for VEGF-A and IL-8 expression
Figure 2 VEGF-A , IL-8 and TNF-α mRNA relative expression (LSmean± S.E.M) in equine monocytes 1, 2 and 4 hours after stimulation
with a hay dust suspension. Alternatively, cells were treated with noscapine (150 μM) one hour before stimulation with the hay dust
suspension. The relative expression is normalized to the geometric mean of reference genes. This experiment is representative of three similar
experiments. (*P< 0.05)
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less dependent on Hif1. Noscapine alone had no effect
on the expression of these three cytokines in equine
monocytes (Figure 2).Horse clinical status assessment
Clinical scores were significantly different between both
the healthy and RAO groups after dust exposure
(Figure 3). In the BALF, neutrophil percentage was
significantly increased in both healthy and RAO horses
following hay dust challenge. However, challenged RAO-
affected horses showed significantly higher neutrophil
percentage than challenged healthy horses. After the
challenge, the percentage of alveolar macrophage (AM)
in the BALF was significantly decreased in RAO-affected
and healthy horses but the decrease was significantly
higher in RAO-affected horses than in healthy horses.
No significant differences were observed between the
percentages in lymphocytes and other cell types. After
dust exposure, arterial blood oxygen partial pressure was
significantly decreased in RAO-affected horses when
compared to healthy horses. The most sensitive value of
impulse oscillometry for RAO-affected horse evaluation,
X5Hz was significantly different between RAO-affected
horses and controls after challenge. Clinical values for
each horse are shown in Table 1.Increased Hif1-α mRNA expression following hay dust
challenge in BALF cells of healthy and RAO-affected
horses
To assess whether our in vitro observations may trans-
late in vivo, we analyzed whether hay dust-induced lung
inflammation in RAO-affected horses was accompanied
by increased Hif1 activity in lung myeloid cells. We first
compared the relative Hif1-α mRNA expression levels in
BALF cells of unchallenged and hay dust-challenged
healthy and RAO-affected horses. No statistically signifi-
cant difference in Hif1-α expression was observed be-
tween unchallenged healthy and RAO-affected horses
(Figure 4). Hif1-α mRNA levels significantly increased in
both healthy and RAO horses following hay dust chal-
lenge. However, challenged RAO-affected horses showed
significantly higher Hif1-α mRNA levels than challenged
healthy horses.
Hif1-α-regulated cytokines are overexpressed in the BALF
cells of RAO-affected horses during crisis
Next, the expression of Hif1 target genes was measured
in BALF cells from hay dust-challenged or unchallenged
healthy and RAO-affected horses (Figure 5). No statisti-
cally significant difference in VEGF-A, IL-8 and TNF-α
expression was observed between the unchallenged
groups. However, we observed that VEGF-A, IL-8 and
TNF-α gene expression was upregulated following hay
Figure 3 Clinical parameters evaluated in vivo in unchallenged and challenged healthy and recurrent airway obstruction-affected
horses. Clinical score, percentage of cells in bronchoalveolar lavage fluid, arterial pressure of oxygen (PaO2) and lung function (X5HZ) were
compared between the groups. This experiment is representative of one protocol performed with five heaves-affected horses and four healthy
horses (*P< 0.05; RAO: recurrent airway obstruction).
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significantly increased in both healthy and RAO-affected
horses upon challenge, whereas VEGF-A levels was
upregulated in challenged RAO-affected but not healthy
horses. We also observed positive correlations between
Hif1-α mRNA expression levels and expression levels of
its target genes (Hif1-α/VEGF-A: r = 0.86; Hif1-α/IL-8:
r = 0.85; Hif1-α/TNF-α: r = 0.78).Correlation between Hif1-α expression in lung myeloid
cells and lung dysfunction
We finally aimed at determining whether Hif1-α expres-
sion in lung myeloid cells correlates with lung dysfunc-
tion and inflammation. Table 2 shows that in challenged
RAO-affected horses, Hif1-α mRNA expression levels
were highly correlated to lung function (X5Hz), arterial
pressure of oxygen (PaO2), and the percentage of neutro-
phils in the BALF (% PMN). The correlations were posi-
tive for neutrophil percentages, and negative for X5Hz
and PaO2. No correlations were observed in challenged
healthy horses.Discussion
Hif1 is increasingly recognized as a master regulator of
inflammatory responses. Recently, it has been demon-
strated that Hif1 activity is increased in the lung of
mouse models of asthma, as well as in BALF cells from
asthmatic patients [24,25]. In the present work, we re-
port similar findings in horses suffering from RAO, a
disease that shares many similarities with human
asthma. We demonstrated that the level of Hif1-α
mRNA expression was significantly increased in BALF
cells of hay dust-challenged horses and that this effect
was more pronounced in RAO-affected than in healthy
animals.
The increase in Hif1-α mRNA expression in BALF
cells of challenged horses may be explained by the pres-
ence of LPS in hay dust. Indeed, it has been previously
demonstrated that LPS induces Hif1-α mRNA expres-
sion through NF-κB activation in human monocytes and
macrophages under normoxic conditions [26]. While ad-
ministration of aerosolized LPS to RAO-affected horses
induces airway neutrophilia, it is not sufficient to elicit
an RAO crisis [5]. At the present time the contribution















Challenged RAO 1 49 21 27 3 62 -0.112 7
RAO 2 48 31 23 2 79 -0.091 6
RAO 3 33 17 47 3 88 -0.045 4
RAO 4 34 21 43 5 82 -0.067 5
RAO 5 40.5 25 33 1.5 86 -0.107 5
Healthy 1 10 24 62 4 105 0.021 2
Healthy 2 12 31 58 1 98 -0.012 3
Healthy 3 8 29 63 0 92 0.013 2
Healthy 4 16 25 57 2 102 0.001 4
Unchallenged RAO 1 5.5 33 60 1.5 86 -0.012 3
RAO 2 6 16 77 1 92 -0.006 3
RAO 3 4 29 65 2 98 0.007 2
RAO 4 2 37 60 1 108 -0.012 2
RAO 5 4.5 19 71 5.5 95 -0.001 3
Healthy 1 2 23 73 2 98 0.028 2
Healthy 2 1.5 19 78.5 1 104 -0.004 2
Healthy 3 1 31 67 1 110 0.003 2
Healthy 4 2.5 15 79.5 3 109 0.011 2
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evidence suggests that a synergistic effect may exist be-
tween inhaled LPS and organic dust particulates. Hif1
activation could also be enhanced by other components
present in the hay dust, such as Alternaria spores, β-Figure 4 The LSmean (±S.E.M.) Hif1-α mRNA relative expression
in bronchoalveolar lavage cells of unchallenged and challenged
healthy and recurrent airway obstruction-affected horses. The
relative expression is normalized to the geometric mean of
reference genes. This experiment is representative of one protocol
performed with five heaves-affected horses and four healthy horses
(*P< 0.05;**P< 0.01; NS = no significant; RAO: recurrent airway
obstruction).Glucans, which also could activate NF- κB [27,28], even
though this hypothesis will require further testing. From
this first study, we suggest that LPS or other compo-
nents present in hay dust may upregulate Hif1-α gene
expression via NF-κB activation in both healthy and
RAO-affected horses, with a more pronounced effect in
RAO-affected horses. It is well known that NF-κB acti-
vation and hypoxia synergistically activate Hif1 [29].
Whereas NF-κB increases Hif1-α mRNA expression
through fixation on a NF-κB site in the promoter of the
Hif1-α gene, hypoxia post-translationally stabilizes the
Hif1-α protein [29]. Accordingly, it has previously been
shown that NF-κB activity is significantly increased in
the lungs of RAO-affected horses during crisis when
compared to unchallenged healthy horses [30]. More-
over, during RAO crises, inflammation induces a hyp-
oxic environment in the lung tissues, which is a
consequence of decreased perfusion, bronchial edema
and increase in metabolic activity of recruited inflamma-
tory cells. Furthermore, as illustrated by our clinical
results, inflammation-induced local tissue hypoxia may
be reinforced by the fact the horses in crisis usually be-
come hypoxemic. Given that Hif1-α mRNA expression
was significantly higher in challenged RAO-affected
horses than in healthy subjects, it is possible that during
the challenge, healthy horses, unlike RAO-affected horses,
do not develop enough lung inflammation to induce
hypoxia and thereby to increase Hif1 activity. A synergy
between NF-κB activation and hypoxia in inflamed air-
ways might thereby potentiate Hif1 activation in RAO.
Figure 5 The LSmean (±S.E.M) relative mRNA expression of the VEGF-A , IL-8 and TNF-α genes in bronchoalveolar lavage cells of
unchallenged and challenged healthy and recurrent airway obstruction-affected horses. The relative expression is normalized to the
geometric mean of reference genes. This experiment is representative of one protocol performed with five heaves-affected horses and four
healthy horses (*P< 0.05;**P< 0.01; NS = no significant; RAO: recurrent airway obstruction).
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this hypothesis.
The observed increase in Hif1-α mRNA expression in
BALF cells of hay dust-exposed horses did not necessar-
ily imply that Hif1 transcriptional activity was increased.
To estimate in vivo whether Hif1 was transcriptionally
active, we could evaluated the expression of known Hif1
target genes. Hay dust challenge induced a significant in-
crease in IL-8 and TNF-α mRNA expression in healthy
and RAO-affected horses, and this increase was signifi-
cantly more pronounced in RAO-affected horses. How-
ever, only challenged RAO-affected horses showed
increased VEGF-A expression. The use of a Hif1-α in-
hibitor indicated that VEGF-A mRNA and IL-8 mRNA
were highly regulated by Hif1 in hay dust stimulated-
monocytes in vitro, in line with reports that Hif1 is able
to regulate VEGF-A and IL-8 in human and murine
macrophages [31]. However, the regulation of TNFα-Table 2 Correlation between Hif1-α mRNA expression and clin
Status Hif1-α mRNA/Neutrophils (%)
Challenged Healthy(n = 4) r =−0.519
RAO-affected(n = 5) r = 0.863 (*)
Coefficient of correlations (r) between Hif1-α mRNA levels in bronchoalveolar lavag
arterial pressure of oxygen PaO2. These values were measured separately in challenmRNA expression in monocytes after hay dust stimula-
tion was only weakly Hif1 dependent. It is likely that hay
dust-induced TNF-α mRNA expression is mainly under
the control of other transcription factor such as NF-κB.
Following LPS stimulation, Hif1 can induce TNF-α tran-
scription by direct fixation to the TNF-α gene promoter
[32]. Yet NF-κB may also induce the transcriptional acti-
vation of TNF-α independently of Hif1 [33].
In an in vitro study, Laan and coll. [34] reported that
IL-8 and TNFα- play a role in RAO. In equine AM stimu-
lated with a hay dust solution, the expression of these
two cytokines is significantly increased in RAO horses
compared to healthy horses [34,35]. In rabbits, lung hyp-
oxia was shown to promote IL-8 production from AM
[36]. Moreover Franchini et al. [37] have suggested that
AM are implicated in the initial inflammatory reaction,
since they demonstrated that release of IL-8 by AM was
required for neutrophil attraction. Taken together, theseical parameters
Hif1-α mRNA/PaO2 (mmHg) Hif1-α mRNA/X5HZ (kPa/L
-1/s)
r = 0.231 r =−0.634
r =−0.881 (*) r =−0.844 (*)
e (BAL) cells and neutrophil percentages in BALF, reactance at 5 Hz (X5HZ), and
ged healthy and recurrent airway obstruction-affected horses. (*P< 0.05)
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acerbation of Hif1 activation in AM might be the initial
response to airborne challenges, followed by an increase
of IL-8 cytokine production and neutrophil invasion.
Currently, we have no information about the role
played by VEGF-A in heaves. VEGF-A is a potent stimu-
lator of vascular angiogenesis, permeability, and remod-
eling that also plays important roles in wound healing
and tissue cytoprotection [38]. The regulation of vascu-
lar permeability is essential for inflammatory processes
in airways, especially in the course of chronic lung dis-
eases [39]. In humans beings and mice, VEGF-A is
involved in the pathophysiology of bronchial asthma
[39,40]. Given the similarities between RAO and asthma
it may be speculated that VEGF-A could play an import-
ant role in RAO pathophysiology.
The expression of these three cytokines positively cor-
related in vitro and in vivo with that of Hif1-α. Even
though our in vitro observations suggest that Hif1 activ-
ity in monocytes may contribute to expression of these
cytokines in vivo, we do not rule out a possible involve-
ment of Hif1 in other cell types.
Moreover even if monocytes are precursors of AM,
they are not terminally differentiated cells. Therefore,
some differences may exist in terms of regulation of
Hif1 expression and activity between monocytes and
AM. For instance, unlike AM, monocytes are unable to
phagocyte and cytokine production and expression of
surface molecules is sometimes different [41]. However,
it is well known in others species that Hif1-α is
expressed by AM [42] and that LPS can induce Hif1-α
in macrophage [34,43]. It is thus highly likely that, like
in monocytes, Hif1-α may be expressed by equine AM
after hay dust challenge. Given the causative role pro-
posed for AM in RAO, increased Hif1-α activity in AM
following hay dust exposure might thus be responsible
for crisis induction in RAO affected- horses.
It could also be worthwhile testing Hif1-α activity in
equine neutrophils after hay dust stimulation. Indeed in
mice, LPS stimulation can induce Hif1 activation in lung
neutrophils [44]. After hay dust exposure, BALF neutro-
phil percentage increases only in RAO-affected horse
and positively correlate with Hif1-α mRNA expression.
Thus, it is possible that in RAO-affected horses, hay
dust-induced neutrophil influx in the lung could also
contribute to upregulated Hif1 activity.
Finally, we have also shown that in challenged RAO-
affected horses the level of Hif1-α expression in BALF
cells correlated with the degree of lung dysfunction. It
will be worthwhile testing whether pharmacological in-
hibition of Hif1 in RAO-affected horses may impact on
disease parameters. Supporting the relevance of this ap-
proach, it was shown that inhibition of Hif1 in mice
using either pharmacological inhibition or conditionalgene deletion significantly reduces airway inflammation
in models of asthma [24,25].
Conclusion
In summary, this study demonstrates that hay dust may
activate Hif1 in horse myeloid cells. It further shows that
lung myeloid cells display increased Hif1 activation upon
hay dust challenge in RAO-affected horses compared to
healthy horses, and that this activation correlates with
disease severity. Our results thus suggest that it would
be worthwhile testing the potential therapeutic benefit
of pharmacological Hif1 inhibition in RAO.
Methods
Experimental animals
Five RAO horses with a history of recurrent episodes of
respiratory distress when exposed to dusty stable envir-
onment (3 females and 2 geldings, median; ranges, 14.5;
9–22 years) and four healthy controls (1 female and 3
geldings, median; ranges, 17.5; 11–28 years) were inves-
tigated in the study. All horses affected by RAO showed
recurrent clinical signs for several years and were there-
fore defined as chronically affected. Several months be-
fore the experiment began, horses were dewormed using
ivermectin and vaccinated against tetanus and equine in-
fluenza. All experiments were conducted with approval
of the Institutional Animal Care and Use Committee of
the University of Liège.
Experimental protocol in vivo
Both groups of horses (RAO and control horses) were
maintained on pasture 3 months before the beginning of
the study to ensure the RAO horses were in clinical re-
mission at the start of the experiment. All clinical and
functional tests were performed on control and RAO
horses in the steady-state (after pasture) and during the
RAO crisis (3 weeks after the onset of the natural chal-
lenge with moldy hay) [45]. Six weeks separated the two
testing periods (Figure 6). The clinical signs in horses
were scored by a masked observer according to a previ-
ously reported system [46]. This protocol was approved
by the Ethics Committee of the University of Liege.
Pulmonary function tests
Pulmonary function was evaluated at rest with an equine
impulse oscillometry system (IOS) Master Screen
(VIASYS Healthcare GmbH, Höchberg, Germany), vali-
dated for the horse [47,48]. Only the reactance at 5 Hz
was used because it is the most sensitive for measuring
changes in mechanical ventilation in the lower respira-
tory system. Before each experiment, the system was
calibrated and the tests were performed without any
prior sedation.
Figure 6 Protocol in vivo: experimental design.
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Arterial blood was anaerobically collected in heparinized
syringes by arterial puncture of the carotid artery with a
20 G 0.9 x 40 mm needle (Terumo Europe, Leuven, Bel-
gium). The blood was immediately analyzed for partial
pressure of oxygen and carbon dioxide (PaO2 and PaCO2)
with the use of an autocalibrated blood gas analyzer
(OPTI CCA; Osmetech, Roswell, Georgia, USA). The
results were corrected for the patient’s body temperature.
Bronchoalveolar lavage fluid cell isolation
The horses were sedated with IV romifidine, (0.01 mg/kg;
Sedivet; Boehringer Ingelheim, Ingelheim, Germany), and
butorphanol (0.02 mg/kg; Torbugesic; Fort Dodge, Wyeth,
Madison, New Jersey, USA). Bronchoalveolar lavage was
performed by instillation of six boluses of 60 mL of sterile
saline with EDTA (0.6 mM) at 37°C into the working
channel of a fiberoptic endoscope (250 cm x 9 mm, Pen-
tax, Breda, The Netherlands) wedged into a bronchus.
The samples recovered from the six syringes were pooled
and immediately placed on ice. An aliquot was collected
for cytological analysis and differential cell counts.
Bronchoalveolar lavage fluid cells were collected by
centrifugation for 7 min at 300 g. The pellet was fil-
tered and washed twice in phosphate buffered saline
(PBS). Cells were resuspended in lysis buffer RA1
(NucleoSpinW RNAII; Macherey-Nagel, Düren, Germany)
according to the manufacturer’s instructions and stored
at −80°C until RNA isolation.
Production of hay dust suspension
Hay dust suspensions were prepared as previously
described by Pirie et al.[49]. Briefly, visibly moldy
patches of hay were manually agitated and the dust col-
lected. Fine dust (1 g) was suspended in 1 mL isotonic
saline (0.9% NaCl) solution and assayed for LPS content.
The quantity of LPS present in the hay dust suspension
(48234 EU/mL) was measured by ELISA (ENdoLISAW;
Hyglos, Bernried am Starnberger See, Germany). The
hay dust suspension was diluted in culture medium to a
concentration of 1 μg/mL (LPS content: 48.234 EU/mL).Isolation of peripheral blood monocytes
Because they required large numbers of cells, these
experiments were conducted on equine monocytes as a
model of equine myeloid cells. Blood was collected from
three healthy adult horses into 2 mM EDTA. The blood
was diluted twice with PBS and layered on Histopaque-
1077 (Sigma Diagnostics, St Louis, MO). After centrifu-
gation at 400 g for 25 min at 4°C, the mononuclear cells
were aspirated and washed twice with ice-cold PBS-
EDTA. The cell pellet was suspended in RPMI-1640 with
10% inactivated fetal bovine serum (FBS), penicillin
(50 U/mL), and streptomycin (50 μg/mL) and after was
incubated at 37°C in 5% CO2 for two hours to permit
adherence of monocytes. Nonadherent cells were
removed by three washes with PBS. The adherent cell
population consisted of >85% monocytes. The mono-
cytes were re-suspended in RPMI-1640 (1×106cells/mL)
and seeded in a 6-well culture plate. Each well received
1 of the following 4 treatments: PBS, hay dust suspen-
sion (1 μg/mL), Noscapine hydrochloride (150 μM;
Sigma-Aldrich, Saint Louis, MO, USA) or Noscapine
hydrochloride (150 μM) combined with a hay dust sus-
pension (1 μg/mL). In order to model a stimulation as
close as possible to the in vivo situation, we chose to
stimulate monocytes with hay dust suspensions.
Noscapine, an inhibitor of Hif1 activity, was added 1
hour before the hay dust suspensions (Figure 7).[50,51]
One, two and four hours after treatments, the mono-
cytes were collected, washed with PBS and lysed in buf-
fer RA1 (NucleoSpinW RNAII; Macherey-Nagel, Düren,
Germany) according to the manufacturer’s instructions
and stored at −80°C until RNA isolation.RNA isolation from blood monocytes and BALF cells and
real-time RT-PCR
Total RNA from blood monocytes and BALF cells was
extracted using NucleoSpinWRNAII (Macherey-Nagel,
Düren, Germany) in presence of Dnase.
Total RNA quantity was measured using a NanodropW
ND-1000 spectrophotometer (Isogen Life Science B.V.,
Figure 7 Protocol in vitro: experimental design.
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reverse transcription using the First Strand cDNA Syn-
thesis kit (Roche, Basel, Switzerland).
Quantitative PCR reactions were performed with IQ
Sybr Green Supermix (Bio-Rad Laboratores, Inc.,
Marne-la-Coquette, France). The reaction master mix
was prepared as recommended by the manufacturer.
To determine whether hay dust-induced Hif1α mRNA
upregulation results in increased Hif1 activity in equine
monocytes. We evaluated Hif1 activation by studying
the level of expression of the Hif1 target genes VEGF-A,
IL-8 and TNF-α. We stimulated or not equine mono-
cytes with hay dust and relative expression of VEGF-A,
IL-8 and TNF-α was assessed by RT-qPCR. Primers for
the targets: Hif1-α, IL-8, VEGF-Alpha, TNF-alpha and
reference genes: ACTB (β-actin), GAPDH (glycérald-
héyde-3 phosphate dehydrogenase), HPRT (hypoxan-
thine phosphoribosyltransferase), RPL32 (ribosomal
protein L32) and SDHA (succinate dehydrogenase com-
plex subunit A) were designed with Primer3Plus soft-
ware and purchased from Eurogentec (Liège, Belgique).
For each investigated gene, GenBank accession numbers,
primer sequences and product size are given in Table 3.
Due to lack of sequence in NCBI database, horse RPL32
sequence was retrieved by probing UCSC horse genome
sequence with human RPL32 mRNA sequence. Primers
were then designed in conserved regions by using Pri-
mer3Plus software.
The cDNA were amplified and quantified in the ICy-
cler iQ real-time PCR detection system (Bio-Rad La-
boratories N.V., Nazareth Eke, Belgium). At the end of
each qPCR, a melt curve was generated to confirm that
a single sequence was amplified for each primer pair.
Agarose gel electrophoresis and the melting curve were
used to assess the specificity of gene amplification. To
confirm reproducibility, all samples were analyzed in du-
plicate on the plate. The entire experiments were per-
formed in triplicate on independent samples. For each
qPCR data analysis, reference genes were analyzed in
parallel.Data analysis
Real-time qPCR results were analyzed using the
QBASE+ software (Biogazelle, Ghent, Belgium), includ-
ing the geNorm tool to assess reference genes stability
(Table 4). Internal control genes were ranked according
to their gene-stability measure M. M is computed by de-
termining, for every control gene, the average pairwise
variation with all other control genes as the standard de-
viation of the logarithmically transformed expression
ratios [52]. Genes with the lowest M values have the
most stable expression. This method constitutes an im-
provement over the classical delta-delta-Ct method,
since it takes into account multiple reference genes,
resulting in improved data normalization. The values
obtained from the in vitro and in vivo study were nor-
malized with the two most stable reference genes RPL32
and HPRT.
Statistical analysis
All data are presented as least square means
(LSmeans) ± associated S.E.M. (standard error of the
mean) for quantitative PCR results. The residual distri-
bution was normally distributed.
During the in vitro study, all four genes were analyzed
using the same mixed model (SAS, Cary, NC). The mod-
els included the “time” factor (with levels T0, T1, T2 and
T4), the “treatment” factor (PBS, dust, noscapine, dust +
noscapine) and the interaction between these two fac-
tors. There was no effect of “time” in the in vitro kinetic.
Correlations between successive measurements made on
the same individual were taken into account using an
auto-regressive residuals structure. The in vitro experi-
ments were repeated at least three times. P < 0.05 was
considered significant.
The clinical values, were analyzed using the PROC
GLM procedure of the SAS package (SAS Institute,
Cary, NC) and a model including “disease status”
(healthy vs RAO), “treatment” (no challenged vs chal-
lenged), and their interactions as fixed effects. Separate
estimates of the least square means of the states, the
Table 3 Primer sequences used for RT-qPCR validation procedure
Genes Equine accession number Primers sequence Product size (bp)
5′———————————————————————————————> 3′
Targets
Hif1-α LOC100061166 Forward ctcaaatgcaagaacctgctc 108
Reverse ttccataccatcttttgtcactg
VEGF-α NM_001081821 Forward tggcagaaggagagcataaaa 123
Reverse actcgatctcatcggggtact
IL-8 NM_001083951 Forward aatgagagcgattgagagtgg 127
Reverse caaaaacgcctgcacaataat
TNF-α EU438779 Forward agcctcttctccttcctcctt 123
Reverse cagagggttgattgactggaa
Housekeeping gene
ACTB NM_001081838.1 Forward ggacctgacggactacctc 81
Reverse cacgcacgatttccctctc
GAPDH NM_001163856 Forward atctgacctgccgcctggag 70
Reverse cgatgcctgcttcaccaccttc
HPRT XM_001490189.2 Forward aattatggacaggactgaacgg 121
Reverse ataatccagcaggtcagcaaag
RPL32 None Forward gggagcaataagaaaacgaagc 113
Reverse cttggaggagacattgtgagc
SDHA XM_001490889.3 Forward gaggaatggtctggaatactg 91
Reverse gcctctgctccataaatcg
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tus and treatments effects have been obtained for each
clinical parameter. P <0.05 was considered significant.
During the in vivo experiment, relative expression
values, as obtained from qBasePlus software, were ana-
lyzed using the PROC GLM procedure of the SAS pack-
age (SAS Institute, Cary, NC) and a model including
“disease status” (healthy vs RAO), “treatment” (no chal-
lenged vs challenged), "gene" (IL-8, Hif1, TNF-α, VEGF-A)
and their interactions as fixed effects. Separate estimates
of the least square means of the states, the treatments and
the interaction between the disease status and treatments
effects have been obtained for each gene". P <0.05 was
considered significant.
To study the correlation between the genes expression
and the physiological parameters (the percentage of neu-
trophils, X5Hz and PaO2) standard least-square linearTable 4 Reference genes stability according to geNorm






Genes with the lowest M values have the most stable expression.regressions were carried out. Coefficients of correlation
of pearson (r) were presented as measures of linear asso-
ciation for regression relationships. Significant differ-
ences of the slopes from zero were determined using a
two-tailed Student's t test. P <0.05 was considered
significant.
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